SHIELD is a partnership of 26 leading research centers, clinical sites, patient groups, and industry partners in 13 European countries. With a shared vision to tackle pancreatic cancer, SHIELD aims to develop a non-invasive blood test for early detection in individuals with high genetic risk, ultimately improving patient outcomes and survival in Europe and in the rest of the world. This project is funded by the European Union, under Grant Agreement no. 101214779. This work has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).
Company Details
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- http://missionshield.eu
- Competitors
- SHIELD EU project, UKC Maribor / University Medical Centre Maribor, SHIELD Project EU, CANDLE Project, MEDViEW EU Project, Intelligent Computer Systems and Applications (ICSA), co-OPERATOR, PCE Pancreatic Cancer Europe, EOSC4Cancer, In Silico Oncology and In Silico Medicine Group ICCS-ECE-NTUA.
Shield Project Questions
Shield Project's website is http://missionshield.eu
Shield Project's LinkedIn profile is https://www.linkedin.com/company/missionshield-eu
Shield Project's industry is
Public Health
Shield Project's top competitors are
Shield Eu Project,
Ukc Maribor / University Medical Centre Maribor,
Shield Project Eu,
Candle Project,
Medview Eu Project,
Intelligent Computer Systems And Applications (Icsa),
Co-Operator,
Pce Pancreatic Cancer Europe,
Eosc4cancer,
In Silico Oncology And In Silico Medicine Group Iccs-Ece-Ntua.
Shield Project's categories are Public Health
